{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["Two", "glucocorticoid", "binding", "sites", "on", "the", "human", "glucocorticoid", "receptor", "."], "sentence": "Two glucocorticoid binding sites on the human glucocorticoid receptor .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "S2", "tokens": ["Glucocorticoids", "are", "known", "to", "have", "a", "lytic", "effect", "in", "leukemic", "cells", "via", "interactions", "with", "the", "glucocorticoid", "receptor", "(", "GR", ")", "."], "sentence": "Glucocorticoids are known to have a lytic effect in leukemic cells via interactions with the glucocorticoid receptor ( GR ) .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "glucocorticoid receptor", "entity_type": "Protein", "start": 15, "end": 16}, {"id": "T2", "text": "GR", "entity_type": "Protein", "start": 18, "end": 18}]}
{"doc_id": "PMID-2205477.txt", "sent_id": "S3", "tokens": ["Cortisol", "and", "various", "synthetic", "glucocorticoids", "bind", "to", "the", "GR", "with", "one-site", "kinetics", "."], "sentence": "Cortisol and various synthetic glucocorticoids bind to the GR with one-site kinetics .", "event_mentions": [], "entity_mentions": [{"id": "T3", "text": "GR", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["Cortivazol", "(", "CVZ", ")", "is", "a", "unique", ",", "high", "potency", "synthetic", "glucocorticoid", ",", "which", "has", "a", "phenylpyrazol", "fused", "to", "the", "A-ring", "of", "the", "steroid", "nucleus", "and", "displays", "binding", "consistent", "with", "two", "or", "more", "sites", "in", "the", "cytosol", "from", "CEM", "C7", "cells", "(", "a", "human", "acute", "lymphoblastic", "T-cell", "line", ")", "."], "sentence": "Cortivazol ( CVZ ) is a unique , high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells ( a human acute lymphoblastic T-cell line ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["It", "has", "previously", "been", "shown", "that", "the", "lower", "affinity", "class", "of", "sites", "are", "similar", "in", "affinity", "and", "site", "molarity", "to", "those", "recognized", "by", "dexamethasone", "."], "sentence": "It has previously been shown that the lower affinity class of sites are similar in affinity and site molarity to those recognized by dexamethasone .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["The", "higher", "affinity", "sites", "bind", "CVZ", "with", "20", "-", "to", "50-fold", "greater", "affinity", ",", "consistent", "with", "CVZ", "'s", "enhanced", "biological", "effects", "."], "sentence": "The higher affinity sites bind CVZ with 20 - to 50-fold greater affinity , consistent with CVZ 's enhanced biological effects .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["In", "mutant", "leukemic", "cells", "resistant", "to", "the", "lytic", "effects", "of", "dexamethasone", ",", "CVZ", "both", "lyses", "the", "cells", "and", "recognizes", "a", "single", "class", "of", "sites", "similar", "to", "the", "high", "affinity", "site", "in", "CEM", "C7", "cells", "."], "sentence": "In mutant leukemic cells resistant to the lytic effects of dexamethasone , CVZ both lyses the cells and recognizes a single class of sites similar to the high affinity site in CEM C7 cells .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "", "tokens": ["We", "have", "carried", "out", "experiments", "to", "define", "the", "nature", "of", "the", "higher", "affinity", "CVZ", "binding", "site", "."], "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2205477.txt", "sent_id": "S9", "tokens": ["We", "now", "show", "that", ":", "1", ")", "CVZ", "has", "more", "than", "one", "binding", "site", "in", "a", "second", ",", "independent", ",", "B-cell", "line", ",", "IM-9", ";", "2", ")", "the", "antiglucocorticoid", "RU", "38486", "is", "able", "to", "block", "both", "CVZ", "'s", "higher", "and", "lower", "affinity", "sites", ";", "3", ")", "all", "of", "CVZ", "'s", "binding", "sites", "are", "on", "a", "protein", "immunologically", "indistinguishable", "from", "the", "human", "GR", ";", "and", "4", ")", "freshly", "isolated", "clones", "of", "CVZ", "-", "resistant", "cells", "have", "lost", "all", "binding", "sites", "for", "CVZ", "."], "sentence": "We now show that : 1 ) CVZ has more than one binding site in a second , independent , B-cell line , IM-9 ; 2 ) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites ; 3 ) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4 ) freshly isolated clones of CVZ - resistant cells have lost all binding sites for CVZ .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "GR", "entity_type": "Protein", "start": 61, "end": 61}]}
{"doc_id": "PMID-2205477.txt", "sent_id": "S10", "tokens": ["These", "data", "indicate", "that", "CVZ", "is", "recognizing", "two", "glucocorticoid", "binding", "sites", "on", "the", "human", "GR", "or", "a", "protein", "very", "similar", "to", "it", "."], "sentence": "These data indicate that CVZ is recognizing two glucocorticoid binding sites on the human GR or a protein very similar to it .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "GR", "entity_type": "Protein", "start": 14, "end": 14}]}
